Immobilized antibodies are useful for the detection of antigens in highly sensitive microarray diagnostic applications. crucial for development of immunobiosensors that can detect a wide variety of analytes including drugs, toxins, bacteria, pathogens, and metabolic biomarkers.17-19 Among the many strategies that have been reported is the use of immobilized forms of antibody binding proteins from (protein A), (protein G), and (protein L) to bind the antibodies to the surface.20 Proteins A and G bind to the Fc region in the heavy chains, while protein L binds to -light chains outside of the antigen binding site. Structural studies show that well-defined motifs C domains E, D, A, B, and C CI-1033 in protein A; C1, D1, and C2 in protein G; B1, B2, B3, and B4 in protein L C are responsible for binding.21 Proteins A, G, and L bind a wide variety of antibodies with different affinities (see Table S1) and have been used to immobilize antibodies in protein-based microarrays.22, 23 The sensitivity of antibody-based assays is increased when the antibodies are immobilized in well-controlled orientations that expose the antigen binding site with enhancements of as much as 100-fold for antibodies bound to immobilized protein A versus randomly oriented binding.24 Several strategies have been used to immobilize antibody-binding proteins, including hydrophobic interactions between a glass surface and protein A, G, or L fusion proteins, cysteine thiol-gold interactions, crosslinking through cysteine and lysine residues, and complementary DNA-DNA interactions.25-28 We now describe procedures for covalently immobilizing truncated versions of proteins A, G, and L, which retain their respective antibody binding motifs, in a well-defined orientation using a regiospecific chemoenzymatic approach based on bioorthogonal reactions that eliminate the need to purify the recombinant proteins at any stage of the process. Glass slides coated with the recombinant proteins A, G, and L selectively bind their respective antibody targets and can be stripped of the antibodies and reused. EXPERIMENTAL SECTION Construction of expression plasmids for antibody-binding proteins with C-terminal CVIA tags Locations encoding the antibody-binding sites in proteins A, G, and L in plasmids SpA-pGEX-KG, proLG-pHD389, and proL-pHD389,29-31 respectively, had been subcloned into pET-28b(+) (Novagen) and each was improved to append a C-terminal RTRCVIA farnesyl transferase identification site towards the portrayed proteins. A 885 bp area coding the E, D, A, B, and C domains of proteins A was amplified with PfuUltra HF DNA polymerase (Stratagene) using primers filled with a 5 NdeI site and a 3 XhoI site (find SI). PCR circumstances (30 CPP32 cycles) had been: preliminary denaturation 95 C, 120 s; denaturation, 95 C, 30 s; annealing 52.1 C, 60 s; expansion 72 C, 60 s; last expansion 72 C, 10 min. The PCR items had been purified on 1% agarose and extracted using the GFX PCR DNA gel purification package (GE health care). The purified PCR fragments and pET28b(+) had been doubly digested with NdeI and XhoI and ligated using T4 DNA ligase (New Britain Biolabs) CI-1033 to provide plasmid pProA-CVIA. XL10-Silver (Stratagene) was changed with pProA-CVIA and specific colonies were selected from LB/Kan (LB with 30 g/mL kanamycin) plates. Plasmid in the transformants was sequenced and isolated to verify the structure from the build. The encoded proteins (proA-CVIA) included five antibody-binding domains CI-1033 (E, D, A, B, and C) from proteins A using a His6-label and a thrombin proteolytic site on the N-terminus and a RTRCVIA farnesyl identification site on the C-terminus. A four amino acidity EEDN series was inserted between RTRCVIA and C-domain. PCR had not been successful with no EEDN insert because of the high homology between domains E, A, D, and B and domains C. Similar appearance plasmids for CVIA-tagged proteins G (proG-CVIA) and proteins L (proL-CVIA) had been built using same method defined for proA-CVIA with minimal adjustments. A 375 bp series encoding the C1, D1, and C2 domains of C40 proteins G was amplified with PfuUltra HF DNA polymerase (Stratagene) using primers filled with a 5 NdeI site and a 3 XhoI site (find SI) and ProLG-pHD389 being a PCR design template. The B1, B2, B3, and B4 domains of proteins L had been amplified with PfuUltra HF DNA polymerase (Stratagene) using primers filled with a 5 NdeI site and a 3 XhoI site (find SI) and ProLG-pHD389 being a PCR template. The PCR circumstances were similar with those employed for pProA-CVIA aside CI-1033 from the annealing methods; 43.7 C for the protein G plasmid and 47.1.
Category Archives: PLA
Categories
- 34
- 5- Receptors
- A2A Receptors
- ACE
- Acetylcholinesterase
- Adenosine Deaminase
- Adenylyl Cyclase
- Adrenergic ??2 Receptors
- Alpha2 Adrenergic Receptors
- Annexin
- Antibiotics
- ATPase
- AXOR12 Receptor
- Ca2+ Ionophore
- Cannabinoid
- Cannabinoid (GPR55) Receptors
- CB2 Receptors
- CCK Receptors
- Cell Metabolism
- Cell Signaling
- Cholecystokinin2 Receptors
- CK1
- Corticotropin-Releasing Factor1 Receptors
- DHCR
- DMTases
- DNA Ligases
- DNA Methyltransferases
- Dopamine D1 Receptors
- Dopamine D3 Receptors
- Dopamine D4 Receptors
- Endothelin Receptors
- EP1-4 Receptors
- Epigenetics
- Exocytosis & Endocytosis
- Fatty Acid Synthase
- Flt Receptors
- GABAB Receptors
- GIP Receptor
- Glutamate (Kainate) Receptors
- Glutamate (Metabotropic) Group III Receptors
- Glutamate (NMDA) Receptors
- Glutamate Carboxypeptidase II
- Glycogen Phosphorylase
- Glycosyltransferase
- GnRH Receptors
- Heat Shock Protein 90
- hERG Channels
- Hormone-sensitive Lipase
- IKK
- Imidazoline Receptors
- IMPase
- Inositol Phosphatases
- Kisspeptin Receptor
- LTA4 Hydrolase
- M1 Receptors
- Matrixins
- Melastatin Receptors
- mGlu Group III Receptors
- mGlu5 Receptors
- Monoamine Oxidase
- Motilin Receptor
- My Blog
- Neutrophil Elastase
- Nicotinic (??4??2) Receptors
- NKCC Cotransporter
- NMU Receptors
- Nociceptin Receptors
- Non-Selective
- Non-selective 5-HT
- OP3 Receptors
- Opioid, ??-
- Orexin2 Receptors
- Other
- Other Oxygenases/Oxidases
- Other Transcription Factors
- p38 MAPK
- p53
- p56lck
- PAF Receptors
- PDPK1
- PKC
- PLA
- PPAR
- PPAR??
- Proteasome
- PTH Receptors
- Ras
- RNA Polymerase
- Serotonin (5-HT2B) Receptors
- Serotonin Transporters
- Sigma2 Receptors
- Sodium Channels
- Steroid Hormone Receptors
- Tachykinin NK1 Receptors
- Tachykinin NK2 Receptors
- Tachykinin, Non-Selective
- Telomerase
- Thyrotropin-Releasing Hormone Receptors
- Topoisomerase
- trpp
- Uncategorized
- USP
Recent Posts
- 2012) using the Phenotypic Characteristic Search for human strains with markers for resistance to Adamantane, Oseltamivir, or both drugs
- Tissue were homogenized into single-cell suspensions and put through red bloodstream cell lysis
- A phase I/II study investigated the safety and efficacy of concurrent local palliative RT and durvalumab (PD-L1 inhibitor) in 10 patients with unresectable or metastatic advanced solid tumors [136]
- We believe that this hypothesis-generating study could open new avenues for exploring oxidative stress as a potential pathogenetic and, hypothetically, therapeutic target for mitigating CLL strong class=”kwd-title” Keywords: Leukemia, Lymphocytic, Gilbert’s, Syndrome Gilbert’s syndrome (GS) is the most common inherited disorder of bilirubin glucuronidation
- Such costs aren’t simple for tertiary-care hospitals in growing countries sometimes, since these already are powered by minimal budget which switches into provision of fundamental medical services mostly, laboratory, radiology, pharmacy services, and bed space
Tags
a 67 kDa type I transmembrane glycoprotein present on myeloid progenitors
and differentiation. The protein kinase family is one of the largest families of proteins in eukaryotes
Apoptosis
bladder
brain
breast
cell cycle progression
cervix
CSP-B
Cyproterone acetate
EGFR) is the prototype member of the type 1 receptor tyrosine kinases. EGFR overexpression in tumors indicates poor prognosis and is observed in tumors of the head and neck
EM9
endometrium
erythrocytes
F3
Goat polyclonal to IgG H+L)
Goat polyclonal to IgG H+L)Biotin)
GRK4
GSK1904529A
Igf1
Mapkap1
monocytes andgranulocytes. CD33 is absent on lymphocytes
Mouse monoclonal to CD33.CT65 reacts with CD33 andtigen
Palomid 529
platelets
PTK) or serine/threonine
Rabbit Polyclonal to ARNT.
Rabbit polyclonal to BMPR2
Rabbit Polyclonal to CCBP2.
Rabbit Polyclonal to EDG4
Rabbit polyclonal to EIF4E.
Rabbit polyclonal to IL11RA
Rabbit polyclonal to LRRIQ3
Rabbit Polyclonal to MCM3 phospho-Thr722)
Rabbit Polyclonal to RBM34
SB 216763
SKI-606
SNX-5422
STK) kinase catalytic domains. Epidermal Growth factor receptor
stomach
stomach and in squamous cell carcinoma.
TNFSF8
TSHR
VEGFA
vulva